Bovine Respiratory Disease Complex: Bacterial Pathogens and Advanced Diagnostics

Introduction

Bovine respiratory disease complex (BRDC) represents a multifactorial syndrome involving viral and bacterial pathogens, environmental stressors, and host immune status. Bacterial pathogens are frequently the final cause of pneumonia and are responsible for substantial economic losses in beef and dairy operations worldwide. This review provides a detailed examination of the primary bacterial agents implicated in BRDC, with a focus on Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni, and explores the evolution of diagnostic methodologies from traditional culture to advanced molecular and metagenomic approaches.

Bacterial Pathogens of BRDC

Mannheimia haemolytica

M. haemolytica is considered the most important bacterial pathogen in BRDC, particularly in feedlot cattle. It is a Gram-negative coccobacillus that colonizes the upper respiratory tract as a commensal. Under stress or viral co-infection, the organism proliferates and translocates to the lower airways, where it initiates a severe fibrinosuppurative bronchopneumonia. The primary virulence factor is leukotoxin A (LktA), a member of the repeats-in-toxin (RTX) family that selectively lyses ruminant leukocytes and platelets, leading to the release of pro-inflammatory mediators and tissue damage. Genomic studies have revealed significant diversity in M. haemolytica serotypes and their virulence gene repertoires. For example, serotype A1 dominates in North American feedlot cattle, while serotype A6 is more prevalent in European calves [1]. This genomic diversity has direct implications for vaccine efficacy and diagnostic target selection.

Pasteurella multocida

P. multocida is a frequent coinfecting agent in BRDC, often isolated from pneumonic lungs concurrently with M. haemolytica or H. somni. It is a Gram-negative coccobacillus that produces a polysaccharide capsule as its major virulence determinant. Capsular serogroups A, B, D, and F are recognized; serogroup A is most commonly associated with bovine respiratory disease. The bacterium can also express dermonecrotic toxin (DNT), which contributes to turbinate atrophy and may exacerbate respiratory pathology. Whole-genome analyses of P. multocida isolates from Norwegian calves have identified a high degree of genetic diversity, with multiple sequence types and variations in virulence-associated genes such as ompH, hgbB, and ptfA [1]. This diversity underscores the need for broader epidemiological surveillance to guide vaccine development.

Histophilus somni

H. somni (formerly Haemophilus somnus) is a Gram-negative coccobacillus that can cause pneumonia, thrombotic meningoencephalitis, myocarditis, and reproductive disorders in cattle. In the respiratory tract, it induces a fibrinous pleuropneumonia that can be indistinguishable from that caused by M. haemolytica on gross pathology. The pathogenesis of H. somni involves immunoglobulin-binding proteins (IbpA and IbpB), which facilitate adherence to host cells, and a biofilm-forming capacity that promotes persistence. The bacterium also possesses the ability to undergo phase variation in surface antigens, complicating immune recognition and diagnostic detection.

Other Bacterial Agents

Mycoplasmopsis bovis (formerly Mycoplasma bovis) is an emerging pathogen in BRDC, particularly in calves and dairy operations. It lacks a cell wall and causes a chronic, caseonecrotic bronchopneumonia that does not respond to beta-lactam antibiotics. Diagnostic detection of M. bovis often requires specialized culture media or PCR assays. Molecular surveillance studies in Western Canadian dairy farms have demonstrated widespread circulation of M. bovis and its association with lung lesions in calves, as assessed by 16S microbiome profiling [2]. Additionally, Trueperella pyogenes is a secondary invader that can cause suppurative pneumonia and lung abscessation, especially when anaerobic conditions prevail following a primary bacterial infection.

Advanced Diagnostic Approaches

Traditional Culture and Identification

Bacterial culture remains a cornerstone for the diagnosis of BRDC, particularly for antimicrobial susceptibility testing (AST). Deep nasopharyngeal swabs or bronchoalveolar lavage fluid are plated onto selective media such as MacConkey agar and Columbia blood agar with a staphylococcal streak. Isolates are identified by colony morphology, Gram stain, and biochemical tests (e.g., oxidase, catalase, and carbohydrate fermentation). However, culture-based methods are limited by their turnaround time (48 to 72 hours), low sensitivity for fastidious organisms like H. somni, and inability to detect M. bovis without specialized media.

Molecular Diagnostics: PCR and RT-qPCR

Polymerase chain reaction (PCR) and quantitative real-time PCR (RT-qPCR) have become routine tools for the rapid and specific detection of BRDC bacterial pathogens. Multiplex PCR panels targeting the lktA gene of M. haemolytica, the kmtt gene of P. multocida, and the 16S rRNA gene of H. somni are widely used. A dual RT-qPCR assay has been developed for the differential detection of bovine rhinitis virus genotypes A and B, illustrating how similar platforms can be adapted for bacterial targets [3]. Reverse transcription qPCR is also essential for detecting RNA viruses such as bovine respiratory syncytial virus (BRSV) and bovine parainfluenza virus type 3 (BPIV3), which often precede bacterial pneumonia. The combination of viral and bacterial targets in a single multiplex panel allows for comprehensive BRDC diagnostics.

Advanced molecular assays also include the use of CRISPR-Cas13a-based amplification-free electrochemical biosensors, as demonstrated for bovine viral diarrhea virus (BVDV) detection [4]. Although designed for viral RNA, this technology is adaptable to bacterial DNA or RNA targets and offers the potential for low-cost, point-of-care diagnostics.

Metagenomic Sequencing

Metagenomic next-generation sequencing (mNGS) represents a paradigm shift in BRDC diagnostics by providing a culture-independent view of the entire microbial community in respiratory specimens. Amplicon sequencing of the 16S rRNA gene enables taxonomic profiling of bacterial populations, while shotgun metagenomic sequencing can simultaneously detect viruses, bacteria, fungi, and antimicrobial resistance genes. A comprehensive study comparing metagenomic and amplicon sequencing for bovine respiratory and enteric diseases revealed that mNGS detects a broader range of pathogens, including those that are difficult to culture, and identifies coinfections that may be missed by targeted PCR [5]. This approach also facilitates the discovery of novel or emerging pathogens, such as new Mycoplasma species or viral agents.

The integration of metagenomic data with host transcriptomic profiling, as shown in a study of preweaned Holstein heifer calves, can reveal the immunopathological mechanisms underlying different stages of BRD [6]. Peripheral leukocyte transcriptomic changes correlate with disease severity and may serve as biomarkers for early detection.

Serological and Immunoassays

Serological detection of antibodies against BRDC pathogens is useful for herd-level surveillance and vaccination monitoring, but has limited diagnostic value for acute cases due to the lag between infection and seroconversion. Indirect enzyme-linked immunosorbent assay (ELISA) based on recombinant proteins, such as the nucleocapsid protein of BPIV3, can provide high sensitivity for diagnosing viral exposure [7]. For bacterial pathogens, ELISA targeting M. haemolytica leukotoxin antibodies or P. multocida capsular antigens are available commercially. However, the cross-reactivity of antibodies among Pasteurellaceae species can complicate interpretation.

Antimicrobial Susceptibility Testing

Antimicrobial resistance (AMR) in BRDC bacterial pathogens is a growing concern. The use of disc diffusion or broth microdilution methods following Clinical and Laboratory Standards Institute (CLSI) guidelines is standard for testing key antibiotics such as oxytetracycline, tilmicosin, florfenicol, tulathromycin, and ceftiofur. The molecular basis of resistance often involves acquired genes (e.g., tet genes for tetracyclines, erm(X) for macrolides, floR for florfenicol) that can be detected by PCR or whole-genome sequencing. Isolates of M. haemolytica and P. multocida with resistance to multiple drug classes have been reported, and the impact of selective treatment protocols on resistance dynamics is an area of active research. In vivo studies have shown that certain non-steroidal anti-inflammatory drugs, such as diclofenac sodium, can alter cardiac biomarkers when administered with antibiotics like tilmicosin, underscoring the need for careful pharmacological monitoring in treated calves [8].

Imaging and Adjunct Diagnostics

Lung ultrasonography has emerged as a non-invasive, rapid diagnostic tool for BRDC, with a Bayesian latent-class modeling meta-analysis confirming its diagnostic accuracy in calves [9]. Ultrasonographic findings such as consolidated lung areas and irregular pleural margins correlate well with pathological changes. However, ultrasound alone cannot differentiate between bacterial and viral etiology, and must be combined with microbial diagnostics.

Diagnostic Workflow

A systematic approach to BRDC diagnosis should integrate clinical examination, imaging, and laboratory testing. The following decision tree illustrates a recommended workflow.

flowchart TD
    A[Clinical signs: fever, cough, dyspnea], > B[Lung ultrasonography]
    B, > C[Detectable consolidation?]
    C, >|No| D[Supportive care, monitor]
    C, >|Yes| E[Deep nasopharyngeal swab or BAL]
    E, > F[Multiplex PCR for bacteria + viruses]
    F, > G[Positive for M. haemolytica, P. multocida, H. somni?]
    G, >|Yes| H[Culture and antimicrobial susceptibility testing]
    G, >|No| I[Metagenomic sequencing if suspicion high]
    H, > J[Select targeted antimicrobial therapy]
    I, > J
    J, > K[Re-evaluate after 48-72 hours]

Conclusion

The bacterial component of BRDC remains a formidable challenge in cattle production. Advances in molecular diagnostics, particularly real-time PCR and metagenomic sequencing, have greatly improved our ability to rapidly identify the causative agents and monitor antimicrobial resistance patterns. The integration of these tools into routine veterinary practice, alongside imaging and clinical assessment, enables more precise treatment decisions and better herd-level management. Continued genomic surveillance of pathogens such as M. haemolytica, P. multocida, and M. bovis is essential for tracking the emergence of hypervirulent clones and resistant strains, and for guiding the development of effective vaccines and control strategies.

References

[1] Ahmadi A, Oma VS, Ånestad LM, et al. Genomic diversity and virulence of Pasteurella multocida in Norwegian calves. Microb Genom. 2026. https://pubmed.ncbi.nlm.nih.gov/42257689/

[2] Wester RJ, Samera GJ, Walcott JR, et al. Molecular surveillance of Mycoplasmopsis bovis across dairy farms in Western Canada and 16s microbiome assessment in pneumonic calves. J Dairy Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42092549/

[3] Liu L, Xiang J, Shi Y, et al. Development and application of a dual RT-qPCR assay for the differential detection of bovine rhinitis virus genotypes A and B. J Virol Methods. 2026. https://pubmed.ncbi.nlm.nih.gov/42248256/

[4] Li Y, Wen D, Zhou Z, et al. A CRISPR-Cas13a-based amplification-free electrochemical biosensor for rapid detection of bovine viral diarrhea virus. Sheng Wu Gong Cheng Xue Bao. 2026. https://pubmed.ncbi.nlm.nih.gov/42009554/

[5] Abedien ZU, Lean IJ, Djordjevic SP, et al. Next-generation detection in bovine respiratory and enteric diseases: metagenomic and amplicon sequencing insights into microbial diversity. Front Vet Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42022392/

[6] Makratzakis LC, Velasco JA, Stegelmeier NC, et al. Peripheral leukocyte transcriptomic changes in preweaned Holstein heifer calves with varying stages of Bovine Respiratory Disease. PLoS One. 2026. https://pubmed.ncbi.nlm.nih.gov/42133642/

[7] Liao J, Yang X, Li R, et al. Development of an indirect enzyme-linked immunosorbent assay based on the nucleocapsid protein of bovine parainfluenza virus type 3. Front Cell Infect Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42100657/

[8] Doğan E. Effects of diclofenac sodium and tilmicosin on cardiac biomarkers in calves with bovine respiratory disease complex. Acta Vet Hung. 2026. https://pubmed.ncbi.nlm.nih.gov/42018377/

[9] Buczinski S, Gomes V, Vergnes G, et al. Lung ultrasonography used as a diagnostic test for respiratory disease diagnosis in calves: systematic review and meta-analysis using a Bayesian latent-class modelling approach. J Dairy Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42114745/

[10] Sang H, Kim T, Kumar R, et al. Novel BPI3Vc-vectored chimeric BVDV antigens elicit broadly neutralizing antibodies in cattle. Front Immunol. 2026. https://pubmed.ncbi.nlm.nih.gov/42233013/

[11] Wang Z, Fan X, Bai B, et al. Polyglutamine-Expanded Ataxin-3 Accelerates CFTR Degradation Through K63-Linked Ubiquitination to Exacerbate Microglial Inflammation. ASN Neuro. 2026. https://pubmed.ncbi.nlm.nih.gov/42189036/

[12] Russell T, Sulçe M, Hoda A, et al. Detection of viruses associated with bovine respiratory disease complex in samples collected from Albanian cattle during 2022/2023. Access Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42095138/

[13] Ren L, Tian C, Shen C, et al. Epidemiological Insights Into BVDV and IBRV in Feeder Cattle After Cross-Regional Transport in China 2022-2024: Coinfection Dynamics and Implications for BRDC Control. Transbound Emerg Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/41982334/

[14] Yu R, Yang W, Liu X, et al. Development and evaluation of a P. multocida A-M. haemolytica A6-rLkt combined vaccine for enhanced control of bovine respiratory disease complex. Microb Pathog. 2026. https://pubmed.ncbi.nlm.nih.gov/41974357/

[15] Foster RC, Gouvêa VN, Beck MR, et al. Effects of gut barrier dysfunction during a viral respiratory disease challenge on immune function of feedlot beef calves. J Anim Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/41968102/